Ideaya Biosciences
IPOImproving lives through transformative precision medicines
Public · South San Francisco, United States · Founded 2015 · $140.0M raised
- Headquarters
- South San Francisco, California
- Employees
- 201–500
- Founded
- 2015
- Business Model
- B2B
- Website
- ideayabio.com
- Total Funding
- $140.0M
- Last Round
- $46.0M Series AJul 2024
- Type
- Public
About
IDEAYA Biosciences is a clinical-stage precision medicine oncology company focused on synthetic lethality targets and translational biomarkers. Listed on NASDAQ (IDYA).
Summary
Ideaya Biosciences is a Biotech company based in South San Francisco, United States, founded in 2015. It has raised $140.0M in total, most recently a $46.0M Series A round in Jul 2024.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Funding History
No funding data available yet.
Know something? Help us improve our data.
Similar Companies
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Novel DNA sequencing architecture to scale the ultra low cost whole genome
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...